TABLE 4.
Area under the dose‐response curve (%CD63+ basophils by concentration of the allergen test solutions [mg/ml]) from patients and controls for gluten and ω5‐, ω1,2‐, α‐, and γ‐gliadins and HMW‐GS/LMW‐GS
| Gluten | ω5‐gliadins | ω1,2‐gliadins | α‐gliadins | γ‐gliadins | HMW‐GS | LMW‐GS | |
|---|---|---|---|---|---|---|---|
| p1 | 44.4 | 114.2 | 44.0 | 54.4 | 10.6 | 28.0 | 46.9 |
| p2 | 12.6 | 4.9 | 24.9 | 39.4 | 18.7 | 35.2 | 41.1 |
| p3 | 2.8 | 3.8 | 4.2 | 7.9 | 7.3 | 17.2 | 40.7 |
| p4 | 5.4 | 7.0 | 6.6 | 8.4 | 9.0 | 19.0 | 20.5 |
| p5 | 2.8 | 6.5 | 2.6 | 2.6 | 3.7 | 3.7 | 3.1 |
| p6 | 44.8 | 80.8 | 48.7 | 63.8 | 49.0 | 49.7 | 80.7 |
| p7 | 1.7 | 6.5 | 3.0 | 0.4 | 0.8 | 0.9 | 2.3 |
| p8 | 3.0 | 44.3 | 1.1 | 1.9 | 3.3 | 1.3 | 0.5 |
| p9 | 170.4 | 232.2 | 108.1 | 163.7 | 156.2 | 102.9 | 172.1 |
| p10 | 9.4 | 50.7 | 3.1 | 3.7 | 4.0 | 8.4 | 4.3 |
| p11 | 9.8 | 67.2 | 12.4 | 11.8 | 7.9 | 8.7 | 9.3 |
| p12 | 7.5 | 59.8 | 56.6 | 58.1 | 29.9 | 12.9 | 24.6 |
| Range (p) | 1.7–170.4 | 3.8–232.2 | 1.1–108.1 | 0.4–163.7 | 0.8–156.2 | 0.9–102.9 | 0.5–172.1 |
| Median (p) | 26.2 | 56.5 | 26.3 | 34.7 | 25.0 | 24.0 | 37.2 |
| c1 | 3.6 | 3.8 | 2.1 | 1.3 | 2.5 | 1.7 | 2.4 |
| c2 | 3.8 | 3.3 | 1.5 | 6.9 | 8.1 | 1.9 | 6.5 |
| c3 | 6.3 | 3.8 | 5.9 | 6.2 | 6.6 | 8.4 | 6.7 |
| c4 | 4.4 | 4.2 | 4.7 | 4.4 | 5.0 | 7.2 | 5.2 |
| c5 | 2.1 | 2.2 | 3.4 | 1.4 | 3.0 | 4.1 | 3.8 |
| c6 | 9.8 | 16.3 | 9.9 | 8.3 | 11.2 | 7.4 | 9.4 |
| c7 | 3.3 | 3.9 | 5.4 | 3.7 | 5.0 | 4.4 | 6.3 |
| c8 | 1.6 | 2.7 | 2.3 | 2.2 | 3.5 | 0.6 | 1.5 |
| c9 | 3.1 | 18.3 | 2.8 | 1.8 | 5.8 | 4.6 | 3.7 |
| c10 | 1.4 | 2.0 | 3.3 | 1.5 | 1.2 | 1.5 | 1.6 |
| Range (c) | 1.4–9.8 | 2.0–18.3 | 1.5–9.9 | 1.3–8.3 | 1.2–11.2 | 0.6–8.4 | 1.5–9.4 |
| Median (p) | 3.9 | 6.1 | 4.1 | 3.8 | 5.2 | 4.2 | 4.7 |
Abbreviations: c, control; HMW‐GS, high‐molecular‐weight glutenin subunits; LMW‐GS, low‐molecular‐weight glutenin subunits; p, patient.